North America Forced Oscillometry Market is expected to reach US$ 52,498.7 Thousand by 2034

According to The Insight Partners\' research, the North America Forced Oscillometry Market was valued at US$ 33,441.8 Thousand in 2025 and is expected to reach US$ 52,498.7 Thousand by 2034, registering a CAGR of 5.2% from 2026 to 2034.

Integration with AI, digital health, and telehealth, and the rise of hybrid oscillometry systems are among the critical factors attributed to driving the North America forced oscillometry market growth.

The integration of forced oscillometry with artificial intelligence, digital health platforms, and telehealth is revolutionizing respiratory care by enabling precise, continuous, and patient-centered lung function monitoring beyond traditional clinic settings. AI and machine learning algorithms process oscillometry parameters-such as respiratory resistance (R5, R20), reactance (X5), and frequency dependence-to build predictive models that classify respiratory conditions with high accuracy. For example, neural network classifiers trained on oscillometry system profiles can reliably distinguish healthy individuals from those with asthma or COPD, while also flagging early small airway changes that spirometry misses. A PMC study developed an ML model using IOS profiles to categorize patients into no obstruction, asthma, or COPD, achieving an overall accuracy of 0.786 with a neural network classifier, where R5-R20 emerged as key features for differentiation. In distinguishing between COPD and asthma, the model achieved 0.854 accuracy. Cureus validated AI in oscillometry for asthma, detecting resistance and reactance accurately. For early COPD detection, BREATH Hannover\'s AI-combined oscillometry identified small airway dysfunction in 40% of screened individuals, flagging a high-risk group for comorbidities. Researchers are exploring AI-driven predictive analytics in FOT for post-surgical lung function recovery, where algorithms forecast complications based on preoperative impedance profiles.

Portable oscillometry devices, paired with user-friendly mobile apps, allow patients to perform effortless tidal-breathing tests at home; the data are automatically transmitted to secure cloud platforms for real-time clinician review. This connectivity supports telehealth consultations in which physicians analyze trends alongside patient-reported symptoms, promptly adjusting therapies for chronic conditions such as asthma or post-COVID respiratory issues. Digital dashboards empower patients by visualizing their airway mechanics, improving adherence, and self-management. By combining the effort-independent nature of oscillometry with AI-driven insights and remote connectivity, this trend is making advanced lung function assessment accessible to underserved populations, reducing unnecessary hospital visits, and enabling proactive, personalized interventions in everyday respiratory care.

On the contrary, the high equipment and maintenance costs hamper the growth of the North America forced oscillometry market.

North America Forced Oscillometry Market Segmentation Analysis:

• By Product, the North America Forced Oscillometry Market is segmented into Device and Accessories. The Device segment is projected to expand at a CAGR of 4.1% during 2026 - 2034.
• By Device For Product, the North America Forced Oscillometry Market is segmented into Desktop and Portable. The Desktop segment is projected to expand at a CAGR of 3.9% during 2026 - 2034.
• By Accessories For Product, the North America Forced Oscillometry Market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment is projected to expand at a CAGR of 7.8% during 2026 - 2034.
• By Application, the North America Forced Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment is projected to expand at a CAGR of 5.5% during 2026 - 2034.
• By End User, the North America Forced Oscillometry Market is segmented into Hospitals and Clinics, Diagnostic Laboratories, and Other End users. The Hospitals and Clinics segment is projected to expand at a CAGR of 5.5% during 2026 - 2034.

By country, the North America Forced Oscillometry Market is categorized into the United States, Canada, and Mexico. The United States is projected to expand at a CAGR of 5.4% during 2026 - 2034.

Key players operating in the Forced Oscillometry Market are COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, IngMar Medical, GANSHORN Medizin Electronic GmbH, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl, among others.

• In September 2025, Jaeger Medical, a global leader in respiratory diagnostic products, is proud to announce the opening of its new U.S. operations facility in Moreno Valley, California. This state-of-the-art, 42,000-square-foot facility is dedicated to serving the needs of U.S. customers, streamlining product availability and service across the country.
• In May 2025, Vitalograph and Thorasys Forge a Strategic Partnership to Expand Respiratory Diagnostics with the Launch of Tremoflo C2 Oscillometer. The partnership marks the official launch of the tremoflo C2 portable oscillometer in the United States, broadening access to Airwave Oscillometry System AOS; technology for diverse patient groups. Vitalograph\'s customers in the U.S. will now benefit from fully integrated oscillometry as part of their comprehensive respiratory diagnostics range.